HK1075005A1 - Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen - Google Patents

Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen

Info

Publication number
HK1075005A1
HK1075005A1 HK05107332.7A HK05107332A HK1075005A1 HK 1075005 A1 HK1075005 A1 HK 1075005A1 HK 05107332 A HK05107332 A HK 05107332A HK 1075005 A1 HK1075005 A1 HK 1075005A1
Authority
HK
Hong Kong
Prior art keywords
controlled release
matrix film
conjugated estrogen
natural mixtures
film tablets
Prior art date
Application number
HK05107332.7A
Other languages
English (en)
Inventor
Bernd Thumbeck
Klaus Budde
Gerhard Kristen
Margit Wiards
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1075005A1 publication Critical patent/HK1075005A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK05107332.7A 2001-12-14 2005-08-22 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen HK1075005A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129830 2001-12-14
PCT/EP2002/014103 WO2003051336A1 (fr) 2001-12-14 2002-12-12 Comprime pellicule matriciel a liberation controlee de melanges naturels d'oestrogenes conjugues

Publications (1)

Publication Number Publication Date
HK1075005A1 true HK1075005A1 (en) 2005-12-02

Family

ID=8179548

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107332.7A HK1075005A1 (en) 2001-12-14 2005-08-22 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen

Country Status (19)

Country Link
US (1) US8268351B2 (fr)
EP (1) EP1465602B1 (fr)
JP (1) JP4695837B2 (fr)
CN (1) CN100542538C (fr)
AR (1) AR037760A1 (fr)
AT (1) ATE438384T1 (fr)
AU (1) AU2002361396B2 (fr)
BR (1) BR0215044A (fr)
CA (1) CA2470207C (fr)
DE (1) DE50213751D1 (fr)
DK (1) DK1465602T3 (fr)
ES (1) ES2328910T3 (fr)
HK (1) HK1075005A1 (fr)
MX (1) MXPA04005769A (fr)
PL (1) PL205739B1 (fr)
PT (1) PT1465602E (fr)
SI (1) SI1465602T1 (fr)
TW (1) TWI252111B (fr)
WO (1) WO2003051336A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
MXPA04008100A (es) * 2002-02-21 2005-06-17 Biovail Lab Int Srl Formulaciones de liberacion modificada de al menos una forma de tramadol.
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
GB0329498D0 (en) * 2003-12-19 2004-01-28 Novartis Ag Organic compounds
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
EP1679065A1 (fr) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Formulation destinée à la libération contrôlée d'interferone par un copolymère bloc PEGT/PBT
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753767A (en) * 1971-08-02 1973-08-21 Colgate Palmolive Co Method of sugar-coating tablets
DE3535536A1 (de) * 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (fr) * 1987-12-22 1989-06-28 Akzo N.V. Unité de dosage pharmaceutique pour traiter les troubles climactériques et l'ostéoporose
HU9500322D0 (en) * 1994-02-08 1995-03-28 Solvay Deutschland Process for separating estrogenes from the urine of mares with foal
US5458887A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
DE4447714C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
WO1997004752A1 (fr) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Compositions pharmaceutiques d'oestrogenes conjugues et leurs modes d'emploi
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
CN1101682C (zh) * 1996-08-30 2003-02-19 索尔瓦药物有限公司 由牝马尿液获取雌激素的方法
CN1101683C (zh) * 1996-08-30 2003-02-19 索尔瓦药物有限公司 由牝马尿获取雌激素的方法
ES2219697T3 (es) 1996-08-30 2004-12-01 Solvay Pharmaceuticals Gmbh Proceso para la obtencion de estrogenos a partir de la orina de yeguas.
CA2263757C (fr) * 1996-08-30 2007-10-23 Solvay Deutschland Gmbh Procede d'obtention d'oestrogenes a partir d'urine de jument
WO1999007342A1 (fr) * 1997-08-11 1999-02-18 Alza Corporation Forme galenique d'un agent actif a liberation prolongee adaptee a la retention gastrique
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
ATE433318T1 (de) * 1999-02-10 2009-06-15 Pfizer Prod Inc Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
PT1183014E (pt) * 1999-06-14 2003-12-31 Cosmo Spa Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy

Also Published As

Publication number Publication date
MXPA04005769A (es) 2004-09-10
CN100542538C (zh) 2009-09-23
PT1465602E (pt) 2009-09-07
ATE438384T1 (de) 2009-08-15
PL369367A1 (en) 2005-04-18
EP1465602B1 (fr) 2009-08-05
WO2003051336A1 (fr) 2003-06-26
DK1465602T3 (da) 2009-09-28
AR037760A1 (es) 2004-12-01
US20050019408A1 (en) 2005-01-27
AU2002361396B2 (en) 2008-02-14
TWI252111B (en) 2006-04-01
TW200408414A (en) 2004-06-01
ES2328910T3 (es) 2009-11-19
JP2005513059A (ja) 2005-05-12
SI1465602T1 (sl) 2009-12-31
EP1465602A1 (fr) 2004-10-13
JP4695837B2 (ja) 2011-06-08
CN1607943A (zh) 2005-04-20
AU2002361396A1 (en) 2003-06-30
PL205739B1 (pl) 2010-05-31
CA2470207A1 (fr) 2003-06-26
CA2470207C (fr) 2012-07-10
DE50213751D1 (de) 2009-09-17
US8268351B2 (en) 2012-09-18
BR0215044A (pt) 2004-11-03

Similar Documents

Publication Publication Date Title
HK1075005A1 (en) Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen
AU2002327068A1 (en) Immediate release tablet
HK1075007A1 (en) Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2002301845A1 (en) Modified release tamsulosin tablets
IL161525A0 (en) Modified release tamsulosin tablets
EP1191271A3 (fr) Mécanisme pourvu d'activation à distance avec un mécanisme de maintien et libération d'équipement
IL141439A0 (en) Immediate release tablet
AU2003213151A1 (en) Controlled release solid dosage carbamazepine formulations
EP1330921A4 (fr) Boitier de matrice de commutation pour haute disponibilite
EP1411904A4 (fr) Composition pharmaceutique a liberation prolongee
EP1304134A4 (fr) Dispositif auxiliaire permettant de fixer un agent de collage
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
AU2003255871A1 (en) Extended release matrix tablets
AUPR076300A0 (en) Device for high pressure casting
AUPR040900A0 (en) Mould release composition
AU2002212906A1 (en) Device for matrix switching
AU2001284382A1 (en) A controlled release anti-inflammatory formulation and a process for the preparation thereof
AU2001270824A1 (en) Release mechanism
AU2001267530A1 (en) Device for producing filling material
GB0014554D0 (en) Controlled matrix multi-vibrator
AUPQ537700A0 (en) Release mechanism
AU2002334741A1 (en) Modified release dosage forms
AUPR284701A0 (en) Release mechanism

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141212